Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients

被引：0
|
作者：
Cao, Lei [1 ]
Cao, Zhili [1 ]
Liu, Hongsheng [1 ]
Liang, Naixin [1 ]
Bing, Zhongxing [1 ]
Tian, Caijuan [2 ]
Li, Shanqing [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China
[2] Tianjin Marvelbio Technol Co Ltd, Tianjin Marvel Med Lab, Tianjin 300381, Peoples R China
来源：
CURRENT ONCOLOGY | 2022年 / 29卷 / 08期
关键词：
non-small-cell lung cancer; immunotherapy; tumor mutation burden; microsatellite instability; programmed cell death protein-1; gene mutation; IMMUNE CHECKPOINT INHIBITORS; REDUCED FOLATE CARRIER; MICROSATELLITE INSTABILITY; SIGNALING PATHWAY; T-CELL; PD-L1; NSCLC; POLYMORPHISMS; RESISTANCE; THERAPIES;
D O I：
10.3390/curroncol29080451
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Microsatellite instability (MSI), high tumor mutation burden (TMB-H) and programmed cell death 1 ligand 1 (PD-L1) expression are hot biomarkers related to the improvement of immunotherapy response. Two cohorts of non-small-cell lung cancer (NSCLC) were collected and sequenced via targeted next-generation sequencing. Drug analysis was then performed on the shared genes using three different databases: Drugbank, DEPO and DRUGSURV. A total of 27 common genes were mutated in at least two groups of TMB-H-, MSI- and PD-L1-positive groups. AKT1, SMAD4, SCRIB and AXIN2 were severally involved in PI3K-activated, transforming growth factor beta (TGF-beta)-activated, Hippo-repressed and Wnt-repressed pathways. This study provides an understanding of the mutated genes related to the immunotherapy biomarkers of NSCLC.
引用
收藏
页码：5715 / 5730
页数：16
相关论文
共 50 条
  • [11] A Review of Immunotherapy in Non-Small-Cell Lung Cancer
    Capella, Mariana Pilon
    Pang, Steph A.
    Magalhaes, Marcos A.
    Esfahani, Khashayar
    CURRENT ONCOLOGY, 2024, 31 (06) : 3495 - 3512
  • [12] FDA Approves Breakthrough Immunotherapy for Patients With Non-Small-Cell Lung Cancer
    Printz, Carrie
    CANCER, 2017, 123 (02) : 191 - 191
  • [13] Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
    Landi, Lorenza
    D'Inca, Federica
    Gelibter, Alain
    Chiari, Rita
    Grossi, Francesco
    Delmonte, Angelo
    Passaro, Antonio
    Signorelli, Diego
    Gelsomino, Francesco
    Galetta, Domenico
    Giannarelli, Diana
    Parra, Hector Soto
    Minuti, Gabriele
    Tiseo, Marcello
    Migliorino, Maria Rita
    Cognetti, Francesco
    Toschi, Luca
    Bidoli, Paolo
    Piantedosi, Francovito
    Calabro, Luana
    Cappuzzo, Federico
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [14] Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)
    Del Giudice, Teresa
    Staropoli, Nicoletta
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    Barbieri, Vito
    CANCERS, 2024, 16 (10)
  • [15] Imaging Biomarkers to Predict and Evaluate the Effectiveness of Immunotherapy in Advanced Non-Small-Cell Lung Cancer
    Liu, Ying
    Wu, Minghao
    Zhang, Yuwei
    Luo, Yahong
    He, Shuai
    Wang, Yina
    Chen, Feng
    Liu, Yulin
    Yang, Qian
    Li, Yanying
    Wei, Hong
    Zhang, Hong
    Jin, Chenwang
    Lu, Nian
    Li, Wanhu
    Wang, Sicong
    Guo, Yan
    Ye, Zhaoxiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [16] Prognosis of uncommon metastasis in non-small-cell lung cancer patients with mutated EGFR
    Yoshimura, Akihiro
    Tsuji, Taisuke
    Takumi, Chieko
    Hamashima, Ryosuke
    Shiotsu, Shinsuke
    Yuba, Tatsuya
    Hiraoka, Noriya
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [17] Identification of genes associated with non-small-cell lung cancer promotion and progression
    Bankovic, Jasna
    Stojsic, Jelena
    Jovanovic, Dragana
    Andjelkovic, Tijana
    Milinkovic, Vedrana
    Ruzdijic, Sabera
    Tanic, Nikola
    LUNG CANCER, 2010, 67 (02) : 151 - 159
  • [18] Identification and validation of key genes associated with non-small-cell lung cancer
    Ma, Qiang
    Xu, Yuan
    Liao, Hebin
    Cai, Yan
    Xu, Lei
    Xiao, Dan
    Liu, Chang
    Pu, Wenjie
    Zhong, Xiaowu
    Guo, Xiaolan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) : 22742 - 22752
  • [19] Factors associated with recurrent leptomeningeal metastases in patients with EGFR-mutated non-small-cell lung cancer
    Watanabe, Hiroko
    Okauchi, Shinichiro
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (11): : 836 - 838
  • [20] Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to Nivolumab
    Teresa Agullo-Ortuno, M.
    Gomez-Martin, Oscar
    Ponce, Santiago
    Iglesias, Lara
    Ojeda, Laura
    Ferrer, Irene
    Garcia-Ruiz, Inmaculada
    Paz-Ares, Luis
    Pardo-Marques, Virginia
    CLINICAL LUNG CANCER, 2020, 21 (01) : 75 - 85
12345